RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ARDX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Ardelyx stock price down 1.48% on Thursday
(Updated on Mar 28, 2024)

Sell candidate since Mar 13, 2024 Loss -15.51% PDF

The Ardelyx stock price fell by -1.48% on the last day (Thursday, 28th Mar 2024) from $7.41 to $7.30. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 4.69% from a day low at $7.25 to a day high of $7.59. The price has fallen in 6 of the last 10 days and is down by -9.09% for this period. Volume has increased on the last day by 2 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 6 million shares were bought and sold for approximately $46.99 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 3.85% during the next 3 months and, with a 90% probability hold a price between $6.66 and $10.32 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ARDX Signals & Forecast

There are few to no technical positive signals at the moment. The Ardelyx stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $7.59 and $8.67. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, February 09, 2024, and so far it has fallen -25.05%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Ardelyx stock

On the downside, the stock finds support just below today's level from accumulated volume at $6.20 and $6.15. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Ardelyx finds support just below today's level at $6.20. If this is broken, then the next support from accumulated volume will be at $6.15 and $6.05.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.340 between high and low, or 4.69%. For the last week, the stock has had daily average volatility of 4.29%.

Ardelyx is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ARDX) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Ardelyx to open at $7.38, and during the day (based on 14 day Average True Range), to move between $6.86 and $7.74, which gives a possible trading interval of +/-$0.443 (+/-6.08%) up or down from last closing price. If Ardelyx takes out the full calculated possible swing range there will be an estimated 12.15% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $8.18 (12.05%) than the support at $6.20 (15.07%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Ardelyx stock A Buy?

The Ardelyx stock holds several negative signals and despite the positive trend, we believe Ardelyx will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.679 Sell Candidate Unchanged

Predicted Opening Price for Ardelyx of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$7.38 ( 1.05%) $7.30

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ARDX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 7.72 5.71 %
R2 7.59 3.93 %
R1 7.51 2.83 %
Current price: 7.30
Support S1 7.25 -0.729 %
S2 7.17 -1.83 %
S3 7.04 -3.61 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 9.10 24.66 %
R2 8.82 20.82 %
R1 8.18 12.05 %
Current price 7.30
Support S1 6.20 -15.07%
S2 6.15 -15.75%
S3 6.05 -17.12%

FAQ

What is the symbol for Ardelyx Stock and on which exchange is it traded?
The symbol for Ardelyx is ARDX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ardelyx Stock?
The Ardelyx stock holds several negative signals and despite the positive trend, we believe Ardelyx will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Ardelyx Stock?
Ardelyx Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ardelyx Stock.

What's the current price of Ardelyx Stock?
As of the end of day on the 2024-03-28, the price of an Ardelyx (ARDX) share was $7.30.

What is the 52-week high and low for Ardelyx Stock?
The 52-week high for Ardelyx Stock is $10.13 and the 52-week low is $3.16.

What is the market capitalization of Ardelyx Stock?
As of the 2024-03-28, the market capitalization of Ardelyx is 1.727B.

When is the next earnings date for Ardelyx?
The upcoming earnings date for Ardelyx is May 01, 2024.
Click to get the best stock tips daily for free!

About Ardelyx

Ardelyx Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult pat... ARDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT